40
HYPOGLYCEMIC AGENTS Rama B. Rao, M.D. Bellevue Hospital Center/NYUMC New York, N.Y.

HYPOGLYCEMIC AGENTS

  • Upload
    rendor

  • View
    50

  • Download
    4

Embed Size (px)

DESCRIPTION

HYPOGLYCEMIC AGENTS. Rama B. Rao, M.D. Bellevue Hospital Center/NYUMC New York, N.Y. Glycemic Control Agents. Insulin Sulfonylureas Meglitinides: Repaglinide Biguanides: Metformin Thiazolidinediones: Pioglitazone  Glucosidase inhibitors. MUSCLE CELL. I. Glycogen. Storage. P. I. - PowerPoint PPT Presentation

Citation preview

Page 1: HYPOGLYCEMIC AGENTS

HYPOGLYCEMICAGENTS

Rama B. Rao, M.D.

Bellevue Hospital Center/NYUMC

New York, N.Y.

Page 2: HYPOGLYCEMIC AGENTS

Glycemic Control Agents

• Insulin

• Sulfonylureas

• Meglitinides: Repaglinide

• Biguanides: Metformin

• Thiazolidinediones: Pioglitazone Glucosidase inhibitors

Page 3: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

MUSCLE CELL

Storage

P

Pyruvate

Kreb’s Oxidative ATPPhosphorylation

Cycle

I

I

Page 4: HYPOGLYCEMIC AGENTS

Glucose

MUSCLE CELLS

P

Pyruvate

I

Kreb’s ATP

Glycogen

EPINEPHRINEGLUCAGON

OxidativePhosphorylation

Page 5: HYPOGLYCEMIC AGENTS

Glucose

MUSCLE CELLS

P

Pyruvate

I

Kreb’s ATP

KETONES

FFA

PhosphorylationOxidative

Page 6: HYPOGLYCEMIC AGENTS

P

Glycogen

Glucose

BRAIN

Pyruvate

KrebsOxidativePhosphorylation

ATP

KETONES

Page 7: HYPOGLYCEMIC AGENTS

HYPOGLYCEMIA

• Hunger/Anxiety

• Focal neurological deficits

• Confusion

• Seizures

• Coma

• Hypothermia

Page 8: HYPOGLYCEMIC AGENTS

P

Glucose

BRAIN: Anterior Pituitary

ATP

GHEXCITATORY NT

Adrenal medullaCatecholamines

Page 9: HYPOGLYCEMIC AGENTS

Other Manifestations

• Tachycardia

• Tremor

• Diaphoresis

Page 10: HYPOGLYCEMIC AGENTS

ALPHA CELL OF PANCREAS

GLUCAGON

DecreasedGlucose

Catecholamines, Amino acids

Page 11: HYPOGLYCEMIC AGENTS

Glucose

MUSCLE CELLS

P

Pyruvate

I

Kreb’s ATP

Glycogen

EPINEPHRINEGLUCAGON

OxidativePhosphorylation

Page 12: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

LIVER CELL

Storage

I

P

Pyruvate

Kreb’s ATP

EPINEPHRINEGLUCAGON

Oxidative

CyclePhosphorylation

Page 13: HYPOGLYCEMIC AGENTS

Ca2+

PANCREAS: BETA ISLET CELL

Insulin

++ +++++

MEMBRANE DEPOLARIZATION

Page 14: HYPOGLYCEMIC AGENTS

K+

ATP

Ca2+

PANCREAS: BETA ISLET CELL

Insulin

Sulfonylurea, Meglitinides*

+++++

*Repaglinide

Page 15: HYPOGLYCEMIC AGENTS

SULFONYLUREAS

• Risk of hypoglycemia– Fasting– Elderly: variable data– Chronic renal failure

Page 16: HYPOGLYCEMIC AGENTS

SULFONYLUREA INDUCED HYPOGLYEMIA

• Administration of glucose for acute correction

• Decontamination

• Nutrition, IV access

• Admission

Page 17: HYPOGLYCEMIC AGENTS

SULFONYLUREAS

• Monitor potassium, phosphate

• Urinary alkalinization for chlorpropamide

• Octreotide for refractory hypoglycemia

• Observation for at least 12 hours after last dose octreotide

Page 18: HYPOGLYCEMIC AGENTS

Octreotide Dosing

• Adults: 50 g subcutaneously every 6 hours

• Children: 4-5 g/kg/day subcutaneously divided every 6 hours, with maximum not exceeding the adult dose

Page 19: HYPOGLYCEMIC AGENTS

K+

ATP

Ca2+

PANCREAS: BETA ISLET CELL

Insulin

DIAZOXIDE

- - - - -- - -

Page 20: HYPOGLYCEMIC AGENTS

Ca2+

PANCREAS: BETA ISLET CELL

Insulin

OCTREOTIDE

G

Page 21: HYPOGLYCEMIC AGENTS

SUFONYLUREAS: Other Effects

• Inhibition of aldehyde dehydrogenase

• SIADH

Page 22: HYPOGLYCEMIC AGENTS

INSULIN

• Oral exposure is benign

• Parenteral Exposures – Unpredictable in overdose– May be dependent upon quantity injection– Formulation

• Treatment: nutrition, supplemental glucose infusion

Page 23: HYPOGLYCEMIC AGENTS

HYPOGLYCEMICS: MANAGEMENT

• Identify and treat hypoglycemia

• Admission especially if brought to coma or seizure

• Nutrition– Consider enteral infusion of feeds via NG Tube

• Monitor electrolytes

Page 24: HYPOGLYCEMIC AGENTS

GLUCOSE ADMINISTRATION

• Adults– D50W 1 gram/kg

• Children– D25W 0.5-1 gram/kg

– D10 W 0.5-1 gram/kg in neonates

• Infusion of D10 W at a total of 1 gram/kg/hr

• Monitor potassium

Page 25: HYPOGLYCEMIC AGENTS

METFORMIN

• Rarely causes true hypoglycemia

• Adverse reaction– Lactic acidosis only in patients with renal

insufficiency or shock states.– Treatment of lactic acidosis: hemodialysis

• Caveat: Co-ingested substances

Page 26: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

MUSCLE CELL

P

Pyruvate

I

Kreb’s ATPMETFORMIN Oxidative

Phosphorylation

Page 27: HYPOGLYCEMIC AGENTS

Glycogen

LIVER CELL

P

Pyruvate

ATP

METFORMIN

PhosphorylationOxidative

Page 28: HYPOGLYCEMIC AGENTS

OTHER AGENTS AFFECTING CARBOHYDRATE METABOLISM

• Ethanol

• Beta adrenergic antagonists

• Unripened ackee fruit

• Valproic acid

• Salicylates

• Pentamidine

• Quinidine

• Disopyramide

Page 29: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

LIVER CELL

Pyruvate

Oxidative

ATP

Lactate

Phosphorylation

NAD+

NADH+H+

ETHANOL

Acetate

Page 30: HYPOGLYCEMIC AGENTS

ALPHA CELL OF PANCREAS

GLUCAGON

DecreasedGlucose

Catecholamines, Amino acids

BETA ADRENERGICANTAGONISTS

Page 31: HYPOGLYCEMIC AGENTS

Glycogen

LIVER CELL

P

Pyruvate

ATPPhosphorylationOxidative

ACKEE

Page 32: HYPOGLYCEMIC AGENTS

Glucose

LIVER

P

Pyruvate

I

Kreb’s ATP

KETONES

FFA

PhosphorylationOxidative

ACKEEVALPROIC ACID

Page 33: HYPOGLYCEMIC AGENTS

Glucose

LIVER

P

Pyruvate

I

Kreb’s ATP

PhosphorylationOxidative

Alanine

SALICYLATES

Page 34: HYPOGLYCEMIC AGENTS

Ca2+

PANCREAS: BETA ISLET CELL

Insulin

++ +++

Membrane depolarization

PENTAMIDINEALLOXAN

STREPTOZOCIN

Page 35: HYPOGLYCEMIC AGENTS

P

BRAIN

Pyruvate

Kreb’s

OxidativePhosphorylation

ATP

Acetyl Co A

THIAMINE

GLUCOSE

Page 36: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

MUSCLE CELL

Storage

P

Pyruvate

Kreb’s Oxidative ATPPhosphorylation

Cycle

I

I

Page 37: HYPOGLYCEMIC AGENTS

Glucose

MUSCLE CELLS

P

Pyruvate

I

Kreb’s ATP

Glycogen

EPINEPHRINEGLUCAGON

OxidativePhosphorylation

Page 38: HYPOGLYCEMIC AGENTS

Glucose

MUSCLE CELLS

P

Pyruvate

I

Kreb’s ATP

KETONES

FFA

PhosphorylationOxidative

Page 39: HYPOGLYCEMIC AGENTS

P

Glycogen

Glucose

BRAIN

Pyruvate

KrebsOxidativePhosphorylation

ATP

KETONES

Page 40: HYPOGLYCEMIC AGENTS

Glycogen

Glucose

LIVER CELL

Storage

I

P

Pyruvate

Kreb’s ATP

EPINEPHRINEGLUCAGON

Oxidative

CyclePhosphorylation